The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

MDS Files Proxy Circular for Sale of Analytical Technologies Business to Danaher

If you wanted more details of MDS’ deal to sell its analytical technologies business to Danaher, today is your lucky day.  The management proxy circular for the shareholders’ meeting to vote on the deal was filed on EDGAR and SEDAR.  Here’s a direct link to the EDGAR filing.

Bookmark and Share

About these ads

2 responses to “MDS Files Proxy Circular for Sale of Analytical Technologies Business to Danaher

  1. Pingback: Monday Biotech Deal Review: October 12, 2009 « The Cross-Border Biotech Blog

  2. Pingback: Monday Biotech Deal Review: October 25, 2009 « The Cross-Border Biotech Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 129 other followers